IBCC COVID-19 Update #8

1

Introduction

00:00 • 3min

2

Antiquagulation in Critically Inflamed Patients

02:45 • 3min

3

The New Press Release Says There Could Be a Group of Intermediately Ill Patients Who Benefit From Full Therpa Therapy

05:16 • 2min

4

Do I Need a Clear Indication Outside of Covid?

07:17 • 2min

5

Immunomodulation for Pneumonia - What's the Problem?

09:24 • 3min

6

Do I Need a C T Chest?

12:17 • 2min

7

Do You Know What's Going on in Cardiovascars?

14:10 • 4min

8

Is There a Difference Between High Flow Nasal Canula and S Pap?

18:08 • 2min

9

How Does Mean Airway Pressure Improve Recruitment?

20:36 • 2min

10

Is Early Bipap Non-Evasive, Safe, or Should We Just Intimate Early Air Ds?

22:18 • 3min

11

When Do We Intimate These Patients?

24:58 • 2min

12

Venti Low Tidal Volume Ventilation

26:55 • 2min

13

Low Peep Trial - What's the Evidence Base?

29:22 • 3min

14

Is It Safe to Prone Without Paralysis?

32:31 • 2min

15

I'm in the Promise Land, Yo?

34:24 • 3min

16

Hemoglobin

37:03 • 3min

17

Steroid Use

40:30 • 3min

18

Is There a Tose Six Inhibitor?

43:10 • 2min

19

Is There a Better Way to Agrthem?

45:06 • 3min

20

Immunotherapy for the Inflammatory Markers in Patients With a Mild Clinical Illness

48:00 • 2min

21

Ramda, Severe Theory of Busin a Our Hearts?

50:21 • 3min

22

Monoclonal Antibodies

52:52 • 2min

23

DVT Proflaxis and Respiratory Support

54:28 • 2min